Cargando…

Protective Effects of Tiaoganquzhi Decoction in Treating inflammatory Injury of Nonalcoholic Fatty liver Disease by Promoting CGI-58 and Inhibiting Expression of NLRP3 Inflammasome

Tiaoganquzhi Decoction (TGQZD) is a traditional Chinese herbal formulation demonstrated to be a clinically effective treatment for nonalcoholic fatty liver disease (NAFLD), although details concerning its clinical mechanism are poor. This study aimed to explore the mechanism of TGQZD on improvement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Huicun, Gao, Xiang, Chen, Pengmin, Wang, Hongbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108379/ https://www.ncbi.nlm.nih.gov/pubmed/35586044 http://dx.doi.org/10.3389/fphar.2022.851267

Ejemplares similares

Erchen Decoction and Linguizhugan Decoction Ameliorate Hepatic Insulin Resistance by Inhibiting IRS-1Ser307 Phosphorylation In Vivo and In Vitro
por: Zhang, Huicun, et al.
Publicado: (2017)

Reassessing the Potential Activities of Plant CGI-58 Protein
por: Khatib, Abdallah, et al.
Publicado: (2016)

Clinicalpathologic and Prognostic Significance of CGI-58 in Endometrial Cancer
por: Shi, Zhengzheng, et al.
Publicado: (2021)

The lipase cofactor CGI58 controls placental lipolysis
por: Guerrero-Santoro, Jennifer, et al.
Publicado: (2023)

Yanghe Decoction Suppresses the Experimental Autoimmune Thyroiditis in Rats by Improving NLRP3 Inflammasome and Immune Dysregulation
por: Ma, Bing’e, et al.
Publicado: (2021)

Evaluation of NLRP3 inflamassome expression and its endogen inhibitor CGI-58 in subjects with different obesity degrees
por: Rheinheimer, Jakeline, et al.
Publicado: (2015)

Intestinal Cgi-58 Deficiency Reduces Postprandial Lipid Absorption
por: Xie, Ping, et al.
Publicado: (2014)

Western diet induces severe nonalcoholic steatohepatitis, ductular reaction, and hepatic fibrosis in liver CGI-58 knockout mice
por: Yang, Pan, et al.
Publicado: (2020)

Neuroprotective Effect of Taohong Siwu Decoction on Cerebral Ischemia/Reperfusion Injury via Mitophagy-NLRP3 Inflammasome Pathway
por: Ji, Zhao-Jie, et al.
Publicado: (2022)

Protective Effects and Mechanisms of Yinchen Linggui Zhugan Decoction in HFD-Induced Nonalcoholic Fatty Liver Disease Rats Based on Network Pharmacology and Experimental Verification
por: Jiang, Hui, et al.
Publicado: (2022)

Wendan decoction in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis
por: Zhang, Yufeng, et al.
Publicado: (2022)

PNPLA3, CGI‐58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice
por: Wang, Yang, et al.
Publicado: (2019)

Pharmacological effects of Chinese medicine modulating NLRP3 inflammasomes in fatty liver treatment
por: Liu, Tingting, et al.
Publicado: (2022)

Neurodegenerative Disease and the NLRP3 Inflammasome
por: Holbrook, Jonathan A., et al.
Publicado: (2021)

The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
por: Yu, Lili, et al.
Publicado: (2022)

Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure
por: Lu, Yingdong, et al.
Publicado: (2022)

Association between the levels of CGI-58 and lipoprotein lipase in the placenta of patients with preeclampsia
por: Dong, Jianxin, et al.
Publicado: (2021)

Improved Stability of Human CGI-58 Induced by Phosphomimetic S237E Mutation
por: Llamas-García, Miriam Livier, et al.
Publicado: (2022)

Yupingfeng San Inhibits NLRP3 Inflammasome to Attenuate the Inflammatory Response in Asthma Mice
por: Liu, Xue, et al.
Publicado: (2017)

The role of NLRP3 inflammasome in hepatocellular carcinoma
por: Zhao, Huijie, et al.
Publicado: (2023)

Scutellarin Suppresses NLRP3 Inflammasome Activation in Macrophages and Protects Mice against Bacterial Sepsis
por: Liu, Yi, et al.
Publicado: (2018)

C646 Protects Against DSS-Induced Colitis Model by Targeting NLRP3 Inflammasome
por: Xu, Xueming, et al.
Publicado: (2021)

Zerumbone Suppresses the LPS-Induced Inflammatory Response and Represses Activation of the NLRP3 Inflammasome in Macrophages
por: Su, Chia-Cheng, et al.
Publicado: (2021)

Deletion of CGI-58 or adipose triglyceride lipase differently affects macrophage function and atherosclerosis
por: Goeritzer, Madeleine, et al.
Publicado: (2014)

Structure of a CGI-58 Motif Provides the Molecular Basis of Lipid Droplet Anchoring
por: Boeszoermenyi, Andras, et al.
Publicado: (2015)

ATGL/CGI-58-Dependent Hydrolysis of a Lipid Storage Pool in Murine Enterocytes
por: Korbelius, Melanie, et al.
Publicado: (2019)

CGI-58 Protein Acts as a Positive Regulator of Triacylglycerol Accumulation in Phaeodactylum tricornutum
por: Shu, Qin, et al.
Publicado: (2023)

NLRP3 inflammasome and its inhibitors: a review
por: Shao, Bo-Zong, et al.
Publicado: (2015)

Activation of Platelet NLRP3 Inflammasome in Crohn’s Disease
por: Zhang, Ge, et al.
Publicado: (2021)

Dihydrotanshinone I Specifically Inhibits NLRP3 Inflammasome Activation and Protects Against Septic Shock In Vivo
por: Wei, Ziying, et al.
Publicado: (2021)

Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women
por: Zhao, ChenLu, et al.
Publicado: (2023)

Recent evaluation about inflammatory mechanisms in nonalcoholic fatty liver disease
por: Song, Chong, et al.
Publicado: (2023)

Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis
por: Torres, Sandra, et al.
Publicado: (2022)

Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis
por: Ding, Nan, et al.
Publicado: (2020)

Thioredoxin-1 Activation by Pterostilbene Protects Against Doxorubicin-Induced Hepatotoxicity via Inhibiting the NLRP3 Inflammasome
por: Tan, Shiqing, et al.
Publicado: (2022)

Hematopoietic Cell Kinase (HCK) Is Essential for NLRP3 Inflammasome Activation and Lipopolysaccharide-Induced Inflammatory Response In Vivo
por: Kong, Xiangxi, et al.
Publicado: (2020)

CGI-58/ABHD5-Derived Signaling Lipids Regulate Systemic Inflammation and Insulin Action
por: Lord, Caleb C., et al.
Publicado: (2012)

ATGL and CGI-58 are lipid droplet proteins of the hepatic stellate cell line HSC-T6
por: Eichmann, Thomas O., et al.
Publicado: (2015)

Protective Effect of Danshen Zexie Decoction Against Non-Alcoholic Fatty Liver Disease Through Inhibition of ROS/NLRP3/IL-1β Pathway by Nrf2 Signaling Activation
por: Biao, Yaning, et al.
Publicado: (2022)

Disease-Modifying Anti-rheumatic Drug Prescription Baihu-Guizhi Decoction Attenuates Rheumatoid Arthritis via Suppressing Toll-Like Receptor 4-mediated NLRP3 Inflammasome Activation
por: Li, Weijie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s9dii9ti0205i253s8q2jgmi2m